1.Logistic regression analysis on risk factors of overweight and obesity in preschool children
Xinyan CHEN ; Xiumei XIN ; Xuehan WANG ; Jiangwei MA ; Yang ZHU ; Lanying HU ; Yanan KONG ; Hong DING
Chinese Journal of Health Management 2017;11(2):144-147
Objective To analyze the early risk factors of overweight and obesity in preschool children.Methods Using stratified cluster sampling,the data of 1 335 preschool children's physical examination in High-tech Zone,Urumqi,Xinjiang were collected,and the case group had 153 overweight and obese children,the control group had 1 182 non-overweight and obese children;a case-control study was conducted.The basic data of mothers and the basic data of neonatal birth were analyzed retrospectively.The univariate and unconditional multivariate logistic regression analysis was performed.Results The prevalence of overweight and obesity in preschool children in High-tech Zone in Urumqi was 11.5%.Non-conditional multivariate logistic regression analysis showed that children's age (OR=1.31,95% CI:1.07-1.61),mother's pre-pregnancy BMI (OR=1.11 95 %,CI:1.06-1.17) and whether mothers had gestational hypertension (OR=1.99 95%,CI:1.03-3.85) were the risk factors for overweight and obesity in preschool children (P<0.05).Conclusion In Urumqi high school district preschool children's overweight and obesity rate was high;mothers with high BMI before pregnancy,and those with high blood pressure during pregnancy can increase the risk of overweight and obesity in children,preschool children's increased age may increase the risk of overweight and obesity in children.
2. Clinical efficacy of recombinant activated factor Ⅶ a for 16 hematonosis with moderate or severe bleeding
Fan YANG ; Lingjun KONG ; Jiangwei HU ; Na LIU ; Yongfeng SU ; Yuhang LI ; Jianlin CHEN ; Zhiyong YU ; Zhuoqing QIAO ; Qinghan WANG ; Min JIANG
Chinese Journal of Hematology 2017;38(3):216-221
Objective:
To analyze the efficacy of recombinant activated factor Ⅶ a (rF Ⅶ a) on hematonosis with moderate or severe bleeding signs.
Methods:
Of total 16 cases with rF Ⅶ a treatment from May 2013 to May 2016, 8 cases received allogeneic hematopoietic stem cells transplantation (allo-HSCT) and the other were non-transplantation patients. In two groups, there was no significant difference on rF Ⅶ a usage and dosage. 15 patients with acute graft-versus-host disease (aGVHD) after allo-HSCT were control group (without rF Ⅶ a) .
Results:
①The total response rate was 75.0% (6/8) in non-transplantation group and 37.5% (3/8) in transplantation group, respectively. Median interval for hemorrhage stop was 38.5 hours in non-transplantation group and 63.0 hours in transplantation group. The median overall survival (OS) was 201.0 and 29.0 days for non-transplantation group and transplantation group, respectively, and the OS rate was 50.0% (4/8) and 25.0% (2/8) , respectively. The bleeding-related mortality rate was 50.0% (2/4) and 83.3% (5/6) , respectively. ②Of the 16 cases, 9 showed response to rF Ⅶ a treatment and the other 7 cases’bleeding signs did not alleviate. The median OS was 268.0 in 9 cases with response and 24.0 days in 7 cases without response, respectively. ③In patients with intestinal aGVHD complicated with intestinal hemorrhage, the median OS of observation group (
3.Research progress on relationship between exposure to perfluoroalkyl and polyfluoroalkyl substances and allergic diseases
Jiangwei KONG ; Yuqi LI ; Xiaohan LIU ; Yun HOU ; Yan GUI ; Kehu XI ; Xiaobing ZHANG
Journal of Environmental and Occupational Medicine 2023;40(10):1218-1223
Perfluoroalkyl and polyfluoroalkyl substances (PFASs), as a group of persistent organic pollutants among environmental endocrine disruptors, are widely used in industrial production and daily life. PFASs are widely and persistently present in the environment and organisms due to their bioaccumulation, long half-life, and low degradability properties. Published studies have proved that PFASs have immunotoxicity, endocrine toxicity, neurotoxicity, reproductive toxicity, and hepatotoxicity. At present, several epidemiological studies have been conducted on the effects of PFASs on allergic diseases, the research endpoints include asthma, allergic rhinitis, atopic dermatitis, and the expression of allergic biomarkers such as serum immunoglobulin E (IgE), but no consistent results have been observed yet. PFASs have the potential to activate several signaling pathways, including the peroxisome proliferator-activated receptor (PPAR), nuclear factor-κB (NF-κB), and JAK/STAT pathways. These mechanisms, along with increasing mast cell calcium influx and sex hormone synergistic effects, may contribute to immunomodulation in allergic diseases. At present, the exact human effect of PFASs exposure on allergic diseases and the related mechanisms are still uncertain. This review focused on the impacts of PFASs on asthma, allergic rhinitis, and atopic dermatitis and their possible mechanisms, so as to provide research ideas for the prevention, diagnosis, and treatment of allergic diseases.